COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02029378
Brief Title: Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study (ICA-GBS)

First Submitted : January 6, 2014
First Submitted that Met QC Criteria : January 6, 2014
First Posted : January 7, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 22, 2014
Last Update Posted : September 23, 2014 (Estimate)